CONOLIDINE OPTIONS

In a very the latest study, we claimed the identification and the characterization of a whole new atypical opioid receptor with exclusive adverse regulatory Homes to opioid peptides.1 Our effects showed that ACKR3/CXCR7, hitherto called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be a broad-spectrum scavenger for opioid pep